Trade Assist May Not Be Available For All Jump Trades (See Trade Plan

Ticker delayed 20 minutes



Avg Daily Volume: 4,692,630    Market Cap: 2.17B
Sector: None    Short Interest: 10.4


     THIS QTR:   EPS:       .0/share     REV:  204.60/M
     LAST QTR:  EPS:       -.03/share     ACTUAL:  .04/share  (BEAT)
     NEXT QTR:  EPS:       .05/share     REV:  212.22/M
     FULL YR:     EPS:        .23/Share     REV: 858.37/M

*These are the base metrics we will be watching against the actual release numbers


PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 11.08, 11.98, 18.44



*** With market volatility at extremes during the coronavirus pandemic there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before trading. 

Links To Latest News and Headlines

We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly…

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Zuora Inc (NYSE: ZUO) is struggling because it has real competition.Albireo Pharma Inc (NASDAQ: ALBO) is a totally speculative stock, said Cramer. Even if the company hits it out of the park, you won’t make much money, thinks Cramer.Thermo Fisher Scientific Inc. (NYSE: TMO) and Danaher Corporation (NYSE: DHR) are both better companies than Bruker Corporation (NASDAQ: BRKR), said Cramer.Instead of Cloudera Inc (NYSE: CLDR), Cramer would rather buy Snowflake Inc (NYSE: SNOW). He said Cloudera doesn’t have growth and he is not looking for value in that segment.Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is an inexpensive stock and it is going to stay inexpensive because it doesn’t have any growth, said Cramer.Cramer likes, inc. (NYSE: CRM) and he is going to continue to like it as long as Marc Benioff is there.Cramer would buy Barrick Gold Corp (NYSE: GOLD) on this pullback.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * ‘Trading Nation’ Traders Share Their Consumer Discretionary Picks * ‘Halftime Report’ Traders Share Their Thoughts On Guggenheim’s Bristol-Myers Call(C) 2020 Benzinga does not provide investment advice. All rights reserved.

13 Oct, 2020 @ 13:55 by Yahoo! Finance

Cloudera (NYSE: CLDR) reported Q2 sales of $214.34 million. Earnings fell to a loss of $36.53 million, resulting in a 34.54% decrease from last quarter. Cloudera collected $210.46 million in revenue during Q1, but reported earnings showed a $55.81 million loss.Why ROCE Is Significant Changes in earnings and sales indicate shifts in Cloudera’s Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q2, Cloudera posted an ROCE of -0.03%.It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company’s recent performance, but several factors could affect earnings and sales in the near future.View more earnings on CLDRROCE is an important metric for the comparison of similar companies. A relatively high ROCE shows Cloudera is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and earnings per share growth.In Cloudera’s case, the ROCE ratio shows the amount of assets may not be helping the company achieve higher returns. Investors may take this into account before making any long-term financial decisions.Q2 Earnings Insight Cloudera reported Q2 earnings per share at $0.1/share, which beat analyst predictions of $0.06/share.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Stocks That Hit 52-Week Highs On Wednesday * Earnings Scheduled For September 2, 2020(C) 2020 Benzinga does not provide investment advice. All rights reserved.

(Bloomberg) — Snowflake Inc., a software maker whose stock debuted with the biggest U.S. initial public offering in 2020, signed a deal worth millions of dollars with Goldman Sachs Group Inc. earlier this year, people familiar with the matter said.The renewal contract was signed in Snowflake’s second fiscal quarter, which ended in July, said the people, who asked not to be identified discussing a deal that hasn’t been publicly disclosed. Representatives for Snowflake and Goldman Sachs declined to comment. Goldman began using Snowflake’s technology more than two years ago for its Marcus unit and transaction-banking platform, one of the people said.Snowflake’s data-warehouse software is like a vacuum sucking up information strewn across different systems, so that businesses can analyze it all together. The company competes against the cloud-computing divisions of Inc., Microsoft Corp. and Alphabet Inc., as well as open-source vendor Cloudera Inc. and database stalwart Oracle Corp.San Mateo, California-based Snowflake listed on the New York Stock Exchange in September in the largest IPO ever for a software maker. Goldman Sachs acted as one of the lead underwriters for that listing. Since the IPO pricing, the stock has almost doubled to $238, pushing the company’s market value to about $67 billion.Snowflake has sought to sign more large enterprise clients and sees the financial-services industry as a key part of that effort. Capital One Financial Corp., which is known for being early to adopt cloud technology, became a Snowflake client in July 2017. That contract is now valued around $100 million, a person familiar with the situation told Bloomberg in September. Capital One was the first customer for Virtual Private Snowflake, a product for highly regulated industries that handle particularly sensitive data. Capital One also invested in a Snowflake funding round in 2017.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

06 Oct, 2020 @ 15:52 by Yahoo! Finance

Shares of Cloudera (NYSE: CLDR) tumbled 17.5% last month, according to data provided by S&P Global Market Intelligence, as many investors sold their tech stocks following months of gains in the sector. Investors have flocked to tech stocks during the coronavirus pandemic, as lockdowns and social distancing have forced people to spend more time at home. Cloudera’s steep price drop at the beginning of the month appears to follow that same pattern.

StockJumpers analysis and trade plans are uploaded generally 1 HOUR BEFORE MARKETS CLOSE (3PM EST) for most events.

“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up  Looking forward to having you on-board ASAP”

There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory. 

NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.